Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity

被引:169
作者
Fleckenstein, AE [1 ]
Gibb, JW [1 ]
Hanson, GR [1 ]
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
关键词
psychostimulant; dopamine trasporter; amphetamine;
D O I
10.1016/S0014-2999(00)00639-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many psychostimulants alter plasmalemmal monoaminergic transporter function. Some, such as cocaine, prevent the reuptake of newly released dopamine, serotonin or norepinephrine into their associated neurons. Others, such as the amphetamines, facilitate release of these transmitters into the extraneuronal space by causing a reversal of function of these carrier proteins. An understanding of how psychostimulants regulate the function of not only plasmalemmal, but also vesicular monoamine transporter function is important to appreciate the pharmacological and sometimes neurotoxic consequences of administering these drugs, as well as the physiological regulation of these carrier proteins. Hence, this review will describe recent ex vivo studies investigating the rapid and differential affects of several stimulants on both plasmalemmal and vesicular monoamine transporter function. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 105 条
[51]   PHORBOL ESTERS ALTER FUNCTIONS OF THE EXPRESSED DOPAMINE TRANSPORTER [J].
KITAYAMA, S ;
DOHI, T ;
UHL, GR .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (02) :115-119
[52]   LACK OF LONG-TERM MONOAMINE DEPLETIONS FOLLOWING REPEATED OR CONTINUOUS EXPOSURE TO COCAINE [J].
KLEVEN, MS ;
WOOLVERTON, WL ;
SEIDEN, LS .
BRAIN RESEARCH BULLETIN, 1988, 21 (02) :233-237
[53]   Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain [J].
Kokoshka, JM ;
Metzger, RR ;
Wilkins, DG ;
Gibb, JW ;
Hanson, GR ;
Fleckenstein, AE .
BRAIN RESEARCH, 1998, 799 (01) :78-83
[54]   Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters [J].
Kokoshka, JM ;
Vaughan, RA ;
Hanson, GR ;
Fleckenstein, AE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 361 (2-3) :269-275
[55]   EFFECTS OF HIGH-DOSE METHAMPHETAMINE ADMINISTRATION ON SEROTONIN UPTAKE SITES IN RAT-BRAIN MEASURED USING [H-3] CYANOIMIPRAMINE AUTORADIOGRAPHY [J].
KOVACHICH, GB ;
ARONSON, CE ;
BRUNSWICK, DJ .
BRAIN RESEARCH, 1989, 505 (01) :123-129
[56]   Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine [J].
LaVoie, MJ ;
Hastings, TG .
JOURNAL OF NEUROSCIENCE, 1999, 19 (04) :1484-1491
[57]   COMPARISON OF THE RELEASE OF [H-3]DOPAMINE FROM ISOLATED CORPUS STRIATUM BY AMPHETAMINE, FENFLURAMINE AND UNLABELED DOPAMINE [J].
LIANG, NY ;
RUTLEDGE, CO .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (06) :983-992
[58]   A CDNA THAT SUPPRESSES MPP+ TOXICITY ENCODES A VESICULAR AMINE TRANSPORTER [J].
LIU, YJ ;
PETER, D ;
ROGHANI, A ;
SCHULDINER, S ;
PRIVE, GG ;
EISENBERG, D ;
BRECHA, N ;
EDWARDS, RH .
CELL, 1992, 70 (04) :539-551
[59]   DOPAMINE UPTAKE INHIBITORS BLOCK LONG-TERM NEUROTOXIC EFFECTS OF METHAMPHETAMINE UPON DOPAMINERGIC-NEURONS [J].
MAREK, GJ ;
VOSMER, G ;
SEIDEN, LS .
BRAIN RESEARCH, 1990, 513 (02) :274-279
[60]  
McCann UD, 1997, J PHARMACOL EXP THER, V281, P1487